New Salk technology adds methyl groups at specific positions on DNA, allowing targeted gene correction of aberrant epigenetic disorders Salk Institute scientists have developed a novel techn... Read more
Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient’s own cells... Read more
